◆ 会议时间：2020年4月3-7日
◆ 会议地点：奥地利 维也纳
◆ 会议简介：
2020年第39届欧洲放射治疗与肿瘤学会(ESTRO)年会将于2020年4月3-7日在奥地利维也纳举行，ESTRO年会是欧洲最大的放射肿瘤学会议与展览会，同时，2020年世界近距离放射治疗大会将于2020年4月2日至4日在同地举行，点此查看该会议。
欧洲放射治疗与肿瘤学学会(ESTRO)成立于1980年，是一个非营利性科学组织。ESTRO在欧洲内外拥有超过7600名成员，其中包括放射肿瘤学家、医学物理学家、放射生物学家和RTT（放射治疗师）以及肿瘤学界的其他相关专业人员。ESTRO致力于通过代表大会、特别会议、教育课程和出版物等，不断促进放射治疗学在多种肿瘤临床治疗中的应用，以改善对患者的护理。
ESTRO通过组织放射肿瘤学和癌症多学科治疗各方面的会议使其在国际上享有盛誉，其中既有数千名代表参与的大型会议，亦有高度专业化的团体会议。同时，ESTRO也多次与其他国际知名学术组织合作，使会议成为一个能够充分交流知识和经验的平台。
重要日期：
Abstract submission: 23 October 2019
Early registration: 14 January 2020
Late abstract submission: 15 January 2020
Late registration: 3 March 2020
邀请信：It is my privilege and greatpleasure to invite you toESTRO 39 that will take place3-7 April 2020 in Vienna,Austria. We are pleased that this year the WorldCongress of Brachytherapy will take placeadjacent to ESTRO 39 from2-4 April 2019in the same venue as ESTRO 39. ESTRO is a multi-professional societyfocusing on radiation oncology as a corecomponent of high- quality, multidisciplinarycancer treatment, in partnership with otheroncology societies. Radiotherapy is a team effort, deliveredby an interdisciplinary team consisting ofradiation oncologists, clinical oncologists,medical physicists, radiobiologists, radiationtherapists (RTTs) and nurses. The Societywishes to engage them all in their congress,together and indiscussion with otheroncology specialists. In line with the ESTRO vision 2030 ‘RadiationOncology. Optimal Health for all, together’,ESTRO 39 will convey the theme‘Translatingresearch and partnership into optimalhealth’. Advances in technologies and methodologiesof radiation oncology continue to evolveveryrapidly. However, these innovationswill only truly provide impact when thenew findings can be translated into clinicalapplications that will result inoptimalbenefit for each individual patientin daily practice. Radiation oncologyprofessionals should not try to achievesuch optimal outcome by themselves but indialogue and partnership with all relevantstakeholders: other oncology specialists atnational, European and international level;patient representatives and advocates;and, industry partners. ESTRO 39 aims atstimulating all stakeholders to enhance andshape radiotherapy for optimal health foreach cancer patient. The comprehensive scientific programmeat ESTRO 39 offers state-of-the-art teachinglectures, symposia, debates on hot topics,as well as a range of educational activitiessuch as pre-meeting courses, contouringworkshops, and multidisciplinary tumourboards. We put extra effort in optimising theprogramme format of ESTRO 39 by givingmore room and visibility to contributionsfrom abstract submissions. Sessions withhighlights of proffered papers will take placein a plenary setting, offering maximumvisibility to your work. Furthermore, wewill aim to give more visibility to postersby increasing the number of posters thatwill be discussed offering you a platformto showcase your achievements. You aretherefore strongly encouraged to submit anabstract by 23 October 2019 and becomepart of this prestigious event. Late breakingabstract submission will also be possible
as of early January 2020 and within thedeadline of 15 January 2020. The interdisciplinary component of thescientific programme, getting more spacecompared to the past editions, will includesessions on the following topics:
• How can AI improve contouring?
• Spatially fractionated radiation therapy(SFRT) - GRID therapy
• Cancer metabolism: implication forimaging, radiation response predictionand tumor radiosensitisation
• Cardiac radio-ablation
• FLASH: Radiotherapy with ultra-high doserates
• Ultra-hypofractionation for localisedprostate cancer
• Management of complex skin targets:which radiation technique
• MR-guided Radiotherapy: state of the artand future perspectives
• Preventing radiation-induced toxicity forthe H&N region
• Dose accumulation and re-irradiation forbreast and thorax
• How PROMS will change radiotherapypractice
• Targeting microenvironment inradiotherapy: where are we now?
• Redefining oligometastatic disease:incorporating advanced imaging intoclinical trials
• Combined radiotherapy andimmunotherapy in NSCLC Once again young members are workingon preparing a dedicated Young ScientistsTrack encompassing relevant lectures andother activities. This will provide a uniqueopportunity to network and the possibilityof becoming involved in, or even startinginternational and domestic projects. ESTRO 39 houses Europe’s largest industrialexhibition in radiation oncology, offeringyou a unique opportunity to interact withindustry leaders and to find here the latestdevelopments in technology, techniquesand oncology products. We look forward to welcoming you in Vienna. With warm regards, Umberto Ricardi
ESTRO 39 Chair
◆ 参会对象：
政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。
| 
